Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Glatting

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Zeitschrift Fur Medizinische Physik|January 22, 2004
Quantitative image reconstruction in PET from emission data only using cluster analysisMichael Landmann, Gerhard Glatting
Zeitschrift Fur Medizinische Physik|September 19, 2009
Model selection for time-activity curves: the corrected Akaike information criterion and the F-testPeter Kletting, Gerhard Glatting
Cancer Biotherapy & Radiopharmaceuticals|February 17, 2006
Determination of the immunoreactivity of radiolabeled monoclonal antibodies: a theoretical analysisGerhard Glatting, Sven N Reske
Zeitschrift Fur Medizinische Physik|April 20, 2013
Treatment planning in molecular radiotherapyGerhard Glatting, Manuel Bardiès, Michael Lassmann
Frontiers in Nuclear Medicine|October 27, 2025
Population pharmacokinetic modeling in radiopharmaceutical therapy: a reviewDeni Hardiansyah, Bisma Barron Patrianesha, Gerhard Glatting
Zeitschrift Fur Medizinische Physik|May 3, 2011
Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: a simulation studyPeter Kletting, Sven N Reske, Gerhard Glatting
European Journal of Nuclear Medicine and Molecular Imaging|September 11, 2007
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomySven N Reske, Norbert M Blumstein, Gerhard Glatting
Plos One|September 9, 2017
A single-source photon source model of a linear accelerator for Monte Carlo dose calculationObioma Nwankwo, Gerhard Glatting, Frederik Wenz, et al.
Nuklearmedizin. Nuclear Medicine|March 27, 2009
Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistributionFranz Kiraly, Peter Kletting, Sven Reske, et al.
Zeitschrift Fur Medizinische Physik|July 2, 2011
Determination of individual organ masses for (90)Y-anti-CD66 radioimmunotherapy: influence on therapy planningThomas Kull, P Kletting, S N Reske, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Zeitschrift Fur Medizinische Physik|January 22, 2004
Quantitative image reconstruction in PET from emission data only using cluster analysisMichael Landmann, Gerhard Glatting
Zeitschrift Fur Medizinische Physik|September 19, 2009
Model selection for time-activity curves: the corrected Akaike information criterion and the F-testPeter Kletting, Gerhard Glatting
Cancer Biotherapy & Radiopharmaceuticals|February 17, 2006
Determination of the immunoreactivity of radiolabeled monoclonal antibodies: a theoretical analysisGerhard Glatting, Sven N Reske
Zeitschrift Fur Medizinische Physik|April 20, 2013
Treatment planning in molecular radiotherapyGerhard Glatting, Manuel Bardiès, Michael Lassmann
Frontiers in Nuclear Medicine|October 27, 2025
Population pharmacokinetic modeling in radiopharmaceutical therapy: a reviewDeni Hardiansyah, Bisma Barron Patrianesha, Gerhard Glatting
Zeitschrift Fur Medizinische Physik|May 3, 2011
Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: a simulation studyPeter Kletting, Sven N Reske, Gerhard Glatting
European Journal of Nuclear Medicine and Molecular Imaging|September 11, 2007
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomySven N Reske, Norbert M Blumstein, Gerhard Glatting
Plos One|September 9, 2017
A single-source photon source model of a linear accelerator for Monte Carlo dose calculationObioma Nwankwo, Gerhard Glatting, Frederik Wenz, et al.
Nuklearmedizin. Nuclear Medicine|March 27, 2009
Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistributionFranz Kiraly, Peter Kletting, Sven Reske, et al.
Zeitschrift Fur Medizinische Physik|July 2, 2011
Determination of individual organ masses for (90)Y-anti-CD66 radioimmunotherapy: influence on therapy planningThomas Kull, P Kletting, S N Reske, et al.
Pageof 15